Rockville, MD, September 4, 2013 (PRWEB) September 04, 2013
FileTek, Inc., a leading global provider of large-scale data management, Big Data storage virtualization, and active archive solutions, today announced that the SAIC-Frederick, Inc. has selected a StorHouse data management system to be the key component of an innovative tiered storage strategy for vital cancer research data.
SAIC-Frederick is the operations contractor at the National Cancer Institute’s Cancer and Genetics Research Laboratory in Gaithersburg, MD. The lab is a high-throughput, germline genomics facility that utilizes many next-generation, whole-genome assay technologies to support a diverse portfolio of cancer research programs. CGR is both a data generation and bioinformatics analysis resource. The StorHouse project goals are to alleviate existing storage constraints, reduce backup cycles on the laboratory’s primary storage, and provide a highly stable, scalable, and more cost-efficient long-term storage strategy for less active but still critical genotyping and sequencing data.
StorHouse will manage a new Tier 2 storage layer for the ever-growing volume of less frequently accessed genomic data – a category of information too expensive to keep on Tier 1 storage but of critical importance to retain in a cost-effective, managed environment for timely access, research, and analysis. The StorHouse solution will leverage the benefits of using tape in an active archive environment and significantly reduce the amount of genomics data currently stored on costly Tier 1 media.
“The system combines storage management, backup, and archive on a single unified platform while providing enterprise-class data assurance and access at the lowest cost per terabyte of storage,” said Gary Szukalski, President of FileTek.
StorHouse is a storage virtualization and data management platform that blends disk, tape, and the Cloud as part of a scaled-out NAS environment while providing an intelligent backup strategy for Big Data. Because StorHouse abstracts hardware, users see a single unified global namespace rather than specific device types. SSD, JBOD, RAID, MAID, and tape, including LTO varieties, all look like one unlimited storage pool. And by writing/accessing data in native rather than proprietary file format, StorHouse eliminates formal restore procedures and gives users self-service access to all data at any time without IT intervention. No application interfaces or changes to existing applications are required. Other features include full CIFS and NFS connections and security, system automation for ease of use, automatic content validation/repair to eliminate silent corruption/bit rot problems, full LTFS support, and individual backup file deletes on any media, including tape.
FileTek, Inc. is a premier provider of large-scale data management, Big Data Storage virtualization, and active archive solutions, enabling organizations, worldwide and across multiple industry segments, to efficiently manage, rapidly access, and effectively govern their ever-growing volume of enterprise data. Since 1984, FileTek has provided comprehensive, award-winning solutions to companies, prestigious educational institutions, scientific and government agencies worldwide. With our patented and innovative StorHouse high-volume data management solutions, FileTek maintains a steady focus: providing unmatched levels of information access, data assurance, and lowest cost per terabyte of storage for all categories and volumes of data.
FileTek is headquartered at 9400 Key West Avenue, Rockville, MD 20850. Telephone: 301-251-0600. Fax: 301-251-1990. The FileTek international headquarters, FileTek Ltd, is located at One Northumberland Ave., London WC2N 5BW. Telephone: +44 (0) 207 872 5583. Fax: +44 (0) 207 753 2829. The company also has offices across North America. Please visit us at: http://www.filetek.com.
SAIC-Frederick operates the Frederick National Laboratory for Cancer Research, sponsored by the National Cancer Institute, part of the National Institutes of Health. The facility is a government-owned, contractor-operated Federally Funded Research and Development Center based in Frederick, MD and a national resource for technology development and for translating basic scientific discoveries into the next generation of targeted diagnostics and treatments for cancer and AIDS.
This project has been funded in whole or in part with Federal Funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the view of policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.